Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-30T00:39:30.904Z Has data issue: false hasContentIssue false

Disturbance of neurotransmitters monoamines and indices of reducing-oxidizing processes in patient with the first episode of schizophrenia (FES)

Published online by Cambridge University Press:  16 April 2020

V. Kalinina
Affiliation:
Research Institute of Pyisic-Chemical Medicine, Moscow, Russia
Y. Gryzunov
Affiliation:
Research Institute of Pyisic-Chemical Medicine, Moscow, Russia
N. Smolina
Affiliation:
Research Institute of Pyisic-Chemical Medicine, Moscow, Russia
M. Uzbekov
Affiliation:
Research Institute of Psychiatry, Moscow, Russia
E. Misionzhnik
Affiliation:
Research Institute of Psychiatry, Moscow, Russia
G. Dobretsov
Affiliation:
Research Institute of Pyisic-Chemical Medicine, Moscow, Russia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Effective treatment of FES patients may lead to achievement of long-term remission, decrease the number of relapses and increase the level of social activity and quality of life.

Aim

To study some pathophysiological mechanisms of FES.

Methods

The group of patients who were investigated clinically and biochemically consists of 26 persons (11 women and 15 men, average age 28.2 ± 9.5 years) with the first psychotic episode (F20.0; F20.3). Some biochemical parameters, representing the monoaminergic systems, and some biophysical parameters, representing reducing-oxidizing processes, were investigated. These parameters in all patients were estimated following the admission and prior to any treatment.

Results

The severity of the disorder on admission to the clinic according to PANSS score was 75,5 ± 2,2 (i.e., moderately severe). Patients with FES were characterized by a significant increase of platelet momnoamine oxidase activity (by 107%; р < 0,01) and decrease of serum semicarbazide-sensitive amine oxidase activity (by 29%; p < 0,001) in comparison to the controls. Both reactive capability of SH-group (Cys-34 residue) of serum albumin, the main source of thiols of plasma and intersticial fluid, measured in reaction with thiol-specific reagent - dithyonitrobenzoic acide, and kinetic coefficient were decreased in FES patients (by 24%; p = 0,02) in comparison to controls.

Conclusion

These results show that FES patients are characterized by pronounced metabolic disturbances.

Type
P03-243
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.